Research on the in vivo kinetics of gene delivery vectors is ongoing, with studies exploring various aspects such as transgene expression, vector durability, and cell-mediated immunity. Different types of vectors, including viral and non-viral options like AAV and nanoliposomes, are being investigated for their potential in gene therapy. The field appears to be advancing through partnerships and the development of new technologies, with applications in areas like pediatrics and cancer treatment.